![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Chromo Laboratories India Private Limited Pashamylaram In, based in India, is a pharmaceutical company.
One of their significant offerings is Rosuvastatin calcium, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2022-009 - Rev 01
This Chemical Type CEP, issued on May 14, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2631 associated with this CEP further emphasizes